IP Library Granted Patent US 7,044,993
Granted Patent B1
US 7,044,993 · App. 11/169,636 · Granted May 16, 2006

Microbicidal air filter

Assignee: Bolduc Leroux Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,044,993
App. No.
11/169,636
Granted
May 16, 2006
Kind
B1
Abstract

Microbicidal air filter for use with an air passageway, which includes an immobilization network including a plurality of fibers having an amount of at least one antimicrobial agent incorporated and molecularly bonded into a structure thereof sufficient to substantially immobilize, retain and at least inhibit the growth of, or typically kill, microbes suspended in a volume of air moving through the air passageway. The immobilization network is substantially permeable to air. A microbicidal facemask and a microbicidal air filter used in an air circulation system using the immobilization network are disclosed.

Claims (31)

1. Microbicidal air filter for use with an air passageway, said air filter comprising:

an immobilization network including a plurality of fibers having an amount of at least one antimicrobial agent incorporated and molecularly bonded into a structure thereof sufficient to substantially immobilize, retain and at least substantially inhibit the growth of microbes suspended in a volume of air moving through said air passageway, said immobilization network being substantially permeable to said air.

2. The filter, according to claim 1 , in which said at least one antimicrobial agent kills microbes suspended in the volume of air.

3. The filter, according to claim 1 , in which said plurality of fibers arranged in a mesh, said mesh defining a plurality of air spaces between said fibers.

4. The filter, according to claim 3 , in which said fibers are tightly woven or loosely woven.

5. The filter, according to claim 4 , in which said fibers are treated PVC based organic fibers.

6. The filter, according to claim 1 , in which said antimicrobial agent is selected from the group consisting of: an antibacterial agent, an anti-vital agent, an anti-dust mite agent, an anti-mold agent and an anti-yeast agent.

7. The filter, according to claim 6 , in which said antimicrobial agent is TRICLOSAN™.

8. The filter, according to claim 6 , in which said antimicrobial agent is benzyl benzoate.

9. The filter, according to claim 1 , in which said immobilization network is an after-filter so that the air is pre-filtered prior reaching the air passageway.

10. The filter, according to claim 1 , in which said air filter is a facemask configured and sized to fit over the nose and mouth of a user and to be secured therearound.

11. The filter, according to claim 1 , in which said air filter is an air duct filter configured and sized to fit in an air duct system forming the air passageway.

12. The filter, according to claim 11 , in which said air filter further includes:

first and second air permeable screen elements securable together along respective peripheral edges, said screen elements being configured and sized to fit in the air duct system and to be secured therein;

said air permeable immobilization network being located substantially between said first and second screen elements.

13. The filter, according to claim 12 , in which a fastening member connects said first and second air permeable screen elements together to sandwich said immobilization network therebetween.

14. The filter, according to claim 13 , in which said fastening member includes a frame for connecting said first and second screen elements together.

15. The filter, according to claim 14 , in which said fastening member further includes a plurality of stitches located through said immobilization network to divide said immobilization network into subdivisions.

16. Microbicidal facemask comprising:

first and second air permeable screen elements secured together along respective peripheral edges, said screen elements defining a gap therebetween, said screen elements being configured and sized to fit over the mouth and nose of a user and to be secured thereto;

an air permeable immobilization network located in and substantially filling said gap, said immobilization network including a plurality of fibers having an amount of at least one antimicrobial agent incorporated and molecularly bonded into a structure thereof sufficient to substantially immobilize, retain and at least substantially inhibit the growth of microbes suspended in a volume of air moving through said network.

17. The facemask, according to claim 16 , in which said at least one antimicrobial agent kills microbes suspended in the volume of air.

18. The facemask, according to claim 16 , in which said immobilization network includes a plurality of fibers arranged in a mesh, said mesh defining a plurality of air spaces between said fibers.

19. The facemask, according to claim 18 , in which said fibers are tightly woven or loosely woven.

20. The facemask, according to claim 19 , in which said fibers are treated PVC based organic fibers.

21. The facemask, according to claim 16 , in which said antimicrobial agent is selected from the group consisting of an antibacterial agent, an anti-viral agent, an anti-dust mite agent, an anti-mold agent and an anti-yeast agent.

22. The facemask, according to claim 16 , in which said antimicrobial agent is TRICLOSAN™.

23. The facemask, according to claim 16 , in which said antimicrobial agent is benzyl benzoate.

24. The facemask, according to claim 16 , in which said immobilization network is an after-filter so that the air is pre-filtered prior reaching the air passageway.

25. The facemask, according to claim 16 , in which said first air permeable screen element includes a slit located therein of sufficient size to allow said immobilization network to be positioned in said gap.

26. The facemask, according to claim 16 , in which said immobilization network includes RHOVYL'AS™ fibers.

Assignments (6)
MERGER AND CHANGE OF NAME Recorded Jun 9, 2023
From: PROTAIR-X HEALTH SOLUTIONS INC. / SOLUTIONS DE SANTÉ PROTAIR-X INC.; PROTAIR-X TECHNOLOGIES INC./TECHNOLOGIES PROTAIR-X INC.
To: PROTAIR-X TECHNOLOGIES INC./TECHNOLOGIES PROTAIR-X INC.
Reel/Frame 063913/0012 →
CHANGE OF NAME Recorded Jan 19, 2023
From: NOVEKO INC.
To: PROTAIR-X HEALTH SOLUTIONS INC.
Reel/Frame 062436/0308 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF THE ASSIGNOR FROM NOVEK INC. TO NOVEKO INC. PREVIOUSLY RECORDED ON REEL 028544 FRAME 0568. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Aug 2, 2012
From: NOVEKO INC.
To: THIRD EYE CAPITAL CORPORATION
Reel/Frame 028714/0538 →
SECURITY AGREEMENT Recorded Jul 11, 2012
From: NOVEK INC.
To: THIRD EYE CAPITAL CORPORATION
Reel/Frame 028544/0568 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 19, 2008
From: BOLDUC LEROUX INC.
To: NOVEKO INC.
Reel/Frame 021118/0536 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 9, 2006
From: BOLDUC, NORMAND
To: BOLDUC LEROUX INC.
Reel/Frame 017321/0424 →
Continuity (2)
Continuation In Part 1045533700 · Jun 6, 2003
Continuation In Part 0998280400 · Oct 22, 2001